Allient (ALNT) VP awarded 3,032 time- and performance-based shares

Rhea-AI Filing Summary

ALLIENT INC VP and Group President Ashish Bendre reported equity awards of company stock. On March 5, 2026, he acquired a total of 3,032 shares of common stock as stock grants valued at $62.07 per share under the 2017 Omnibus Incentive Plan.

The awards include time-based restricted shares that vest in three equal parts on April 1, 2027, 2028, and 2029, and performance-based restricted shares tied to goals for the years ending December 31, 2025 and December 31, 2026. He also reports 1,155 indirectly held shares through an ESOP Trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bendre Ashish

(Last) (First) (Middle)

C/O ALLIENT INC.

495 COMMERCE DRIVE

(Street)

AMHERST NY 14228

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLIENT INC [ ALNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and Group President

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		1,015(1)	A	$62.07	24,180.975	D
Common Stock	03/05/2026		A		1,015(2)	A	$62.07	25,195.975	D
Common Stock	03/05/2026		A		1,002(3)	A	$62.07	26,197.975	D
Common Stock								1,155	I	By ESOP Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.

2. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2026.

3. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares were earned upon the satisfaction of certain performance goals established by the Compensation Committee for the year ended December 31, 2025 and vest one-third each on April 1, 2026, 2027 and 2028.

	/s/ Michael C. Donlon, Attorney-in-Fact for Ashish Bendre	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the ALLIENT INC (ALNT) Form 4 report for Ashish Bendre?

The Form 4 reports stock awards to VP and Group President Ashish Bendre. On March 5, 2026, he acquired restricted and performance-based common shares under ALLIENT INC’s 2017 Omnibus Incentive Plan, increasing both his direct and indirect equity holdings in the company.

How many ALLIENT INC (ALNT) shares did Ashish Bendre receive?

Ashish Bendre received 3,032 common shares as equity awards. These came through three separate grant transactions on March 5, 2026, each reported at a grant price of $62.07 per share and classified as grants or awards rather than open-market purchases.

What are the vesting terms of the ALLIENT INC (ALNT) restricted share grants?

The restricted shares vest over several years based on time and performance. Time-based shares vest one-third on April 1 of 2027, 2028, and 2029, while performance-based awards vest over a three-year period tied to goals set for 2025 and 2026.

Are the ALLIENT INC (ALNT) awards time-based or performance-based shares?

The awards include both time-based and performance-based restricted shares. Some vest in equal annual installments on April 1 from 2027 through 2029, while others depend on Compensation Committee performance goals for the years ended December 31, 2025 and 2026.

What does indirect ownership by ESOP Trust mean in the ALLIENT INC (ALNT) filing?

The filing shows 1,155 shares held indirectly through an ESOP Trust. This line reflects shares attributed to Ashish Bendre via an employee stock ownership plan trust, classified as indirect ownership separate from his directly held common stock awards.

Were the ALLIENT INC (ALNT) Form 4 transactions open-market buys or equity grants?

The transactions were equity grants, not open-market share purchases. They are coded as awards under transaction code A and described as grants of time-based and performance-based restricted shares pursuant to the company’s 2017 Omnibus Incentive Plan.